{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:01:12Z","timestamp":1789110072934,"version":"build-2803163510"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:00:00Z","timestamp":1182211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The decision to commence or continue use of hormone replacement therapy or oral contraceptives in women presumed or known to be diagnosed with intracranial meningioma is a common clinical question in neurosurgery. A review of the English\u2010language literature was undertaken to examine the association between the use of exogenous hormones and meningioma risk. Seven publications were identified, 6 of which met criteria for inclusion. No randomized clinical trial data were available, hence, results were collected from 2 population\u2010based case\u2010control studies, 2 hospital\u2010based case\u2010control studies, 1 nested case\u2010control study drawn from a large national cohort, and 1 retrospective cohort study. At present, there is no statistical evidence of an increased risk of meningioma among users of oral contraceptives. Although not definitive, available data suggest an association between the use of hormone replacement therapy and increased meningioma risk. Further evaluation of exogenous hormone use in women with meningioma is needed with particular attention to stratification by hormone (ie, estrogen and\/or progesterone) composition, duration of and age at use as well as tumor receptor subtype. Cancer 2007. \u00a9 2007 American Cancer Society.<\/jats:p>","DOI":"10.1002\/cncr.22783","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T18:16:42Z","timestamp":1182277002000},"page":"471-476","source":"Crossref","is-referenced-by-count":93,"title":["Exogenous hormone use and meningioma risk"],"prefix":"10.1002","volume":"110","author":[{"given":"Elizabeth B.","family":"Claus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Bondy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Calvocoressi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joellen M.","family":"Schildkraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Wiemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Wrensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,19]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.21.2.89"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2003.09.031"},{"key":"e_1_2_8_4_2","first-page":"50","article-title":"The molecular biology of hormone and growth factor receptors in meningiomas","volume":"65","author":"Black PM","year":"1996","journal-title":"Acta Neurochirurgica\u2010Supplementum"},{"key":"e_1_2_8_5_2","unstructured":"BlitshteynS CrookJ JaeckleKA.Is there an association between meningioma and hormone replacement therapy? A study of women at the Mayo Clinic Jacksonville. Ninth Annual Meeting of the Society for Neuro\u2010Oncology. November 18\u201321 2004. Abstract EP\u201002."},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006158514866"},{"key":"e_1_2_8_7_2","unstructured":"Central Brain Tumor Registry of the United States (CBTRUS). Available at:http:\/\/www.cbtrus.org\/reports\/\/2005\u20102006\/2006report.pdf(accessed January 8 2007; p 21 Fig. 10)."},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000188281.91351.B9"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.23.1811"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-152"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10410"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1979.50.4.0499"},{"key":"e_1_2_8_13_2","first-page":"252","volume-title":"Epidemiology of Brain Tumors. Cancer in the Nervous System","author":"El\u2010Zein R","year":"2002"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000188735.61994.5b"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01050266"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20776"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000220502.77153.5a"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.3.357"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.1.0113"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.99.5.0848"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<389::AID-IJC2>3.0.CO;2-L"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21950"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013202"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.78.3.0456"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.32.4.305"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1987.66.4.0584"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2006.105.2.163"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.018333"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920515)69:10<2541::AID-CNCR2820691025>3.0.CO;2-H"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj254"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/4.4.278"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.22783","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.22783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:23:54Z","timestamp":1760271834000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.22783"}},"subtitle":["What do we tell our patients?"],"short-title":[],"issued":{"date-parts":[[2007,6,19]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1002\/cncr.22783"],"URL":"https:\/\/doi.org\/10.1002\/cncr.22783","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,19]]}}}